Biologics in Early Osteoarthritis of the Hip 🦴

Created using ChatSlide

This keynote explores the transformative potential of biologic therapies in early hip osteoarthritis (OA), addressing treatment gaps for young symptomatic patients. The session reviews current approaches such as platelet-rich plasma and bone marrow aspirate, alongside the status of stem cell research. Insights into mechanisms, limitations, and the complex nature of hip OA are discussed, paving the way for future advancements in biologic formulations and innovative scaffolds. Emphasising...